Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Waeber

Showing results (121-130 of 458) with videos related to

Pageof 46
Sort By:
Herz|December 1, 1987
[ACE inhibitors and their clinical significance]H R Brunner, B Waeber, J Nussberger
Revue Medicale Suisse|February 8, 2011
[Angiotensin II antagonists and cancer: a storm that can do good ]B Waeber, A Pechère-Bertschi, M Burnier
Journal of Steroid Biochemistry|October 1, 1988
Clinical applications of antimineralocorticoidsB Waeber, J Nüssberger, H R Brunner
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|November 30, 1993
[The importance of therapy compliance in the treatment of arterial hypertension]B Waeber, G Heynen, H R Brunner
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1994
The advantages of angiotensin II antagonismM Burnier, B Waeber, H R Brunner
European Heart Journal|December 1, 1994
Dose-response relationships of ACE inhibitors and angiotensin II blockersH R Brunner, J Nussberger, B Waeber
Journal of Cardiovascular Pharmacology|January 1, 1985
The present molecules of converting enzyme inhibitorsH R Brunner, J Nussberger, B Waeber
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 1, 1992
Conclusions on the measurement of arterial wall thickness: anatomic, physiologic and methodologic considerationsR B Devereux, B Waeber, M J Roman
Praxis|March 3, 2007
[Sudden death in young athletes]B Gojanovic, F Feihl, G Gremion, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physiciansM D Schaller, B Waeber, H R Brunner
Pageof 46

Showing results (121-130 of 458) with videos related to

Sort By:
Pageof 46
Herz|December 1, 1987
[ACE inhibitors and their clinical significance]H R Brunner, B Waeber, J Nussberger
Revue Medicale Suisse|February 8, 2011
[Angiotensin II antagonists and cancer: a storm that can do good ]B Waeber, A Pechère-Bertschi, M Burnier
Journal of Steroid Biochemistry|October 1, 1988
Clinical applications of antimineralocorticoidsB Waeber, J Nüssberger, H R Brunner
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|November 30, 1993
[The importance of therapy compliance in the treatment of arterial hypertension]B Waeber, G Heynen, H R Brunner
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1994
The advantages of angiotensin II antagonismM Burnier, B Waeber, H R Brunner
European Heart Journal|December 1, 1994
Dose-response relationships of ACE inhibitors and angiotensin II blockersH R Brunner, J Nussberger, B Waeber
Journal of Cardiovascular Pharmacology|January 1, 1985
The present molecules of converting enzyme inhibitorsH R Brunner, J Nussberger, B Waeber
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 1, 1992
Conclusions on the measurement of arterial wall thickness: anatomic, physiologic and methodologic considerationsR B Devereux, B Waeber, M J Roman
Praxis|March 3, 2007
[Sudden death in young athletes]B Gojanovic, F Feihl, G Gremion, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physiciansM D Schaller, B Waeber, H R Brunner
Pageof 46